These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11222177)

  • 1. [Molecular biology of hepatitis C virus: implications for the development of new therapies and prophylactic vaccine].
    Forns X
    Med Clin (Barc); 2001 Feb; 116(5):191-7. PubMed ID: 11222177
    [No Abstract]   [Full Text] [Related]  

  • 2. Is hepatitis C virus eradication a realistic objective in the absence of a prophylactic vaccine?
    Roingeard P
    Liver Int; 2016 Jul; 36(7):1076. PubMed ID: 26836756
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA vaccines for hepatitis C virus.
    Brinster C; Inchauspé G
    Intervirology; 2001; 44(2-3):143-53. PubMed ID: 11509875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular aspects of the antiviral response against hepatitis C virus implicated in vaccines development].
    Llanes MS; Palacios NS; Piccione M; Ruiz MG; Layana C
    Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):273-80. PubMed ID: 24529681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and vaccination for hepatitis C: present and future.
    Jawaid A; Khuwaja AK
    J Ayub Med Coll Abbottabad; 2008; 20(1):129-33. PubMed ID: 19024206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenge of developing a vaccine against hepatitis C virus.
    Forns X; Bukh J; Purcell RH
    J Hepatol; 2002 Nov; 37(5):684-95. PubMed ID: 12399239
    [No Abstract]   [Full Text] [Related]  

  • 7. [Subgenomic replications of hepatitis C virus (HCV): new possibilities for hepatitis C prophylaxis and treatment].
    Puig-Basagoiti F; Sáiz JC
    Gastroenterol Hepatol; 2001 Dec; 24(10):506-10. PubMed ID: 11730621
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses.
    Houghton M
    Immunol Rev; 2011 Jan; 239(1):99-108. PubMed ID: 21198667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies and prospects for vaccination against the hepatitis C viruses.
    Houghton M
    Curr Top Microbiol Immunol; 2000; 242():327-39. PubMed ID: 10592667
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a hepatitis C virus vaccine.
    Inchauspé G; Feinstone S
    Clin Liver Dis; 2003 Feb; 7(1):243-59, xi. PubMed ID: 12691469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phantom menace.
    Rinaldi A
    EMBO Rep; 2006 Jan; 7(1):14-7. PubMed ID: 16391530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapeutic options for hepatitis C.
    Waters L; Nelson M
    Curr Opin Infect Dis; 2006 Dec; 19(6):615-22. PubMed ID: 17075339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The current concepts of viral hepatitis C].
    Gendon IuZ
    Vopr Virusol; 1991; 36(4):268-74. PubMed ID: 1665618
    [No Abstract]   [Full Text] [Related]  

  • 14. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
    Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
    J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis C virus: troublesome vaccination and treatment].
    Carreño V
    Rev Clin Esp; 1993 Mar; 192(4):155-6. PubMed ID: 8386842
    [No Abstract]   [Full Text] [Related]  

  • 16. The American Association For the Study of Liver Diseases: new perspectives in the treatment of hepatitis C.
    Zeuzem S
    Antivir Ther; 2006; 11(2):267-71. PubMed ID: 16640108
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunogenicity and heterologous protection in mice with a recombinant adenoviral-based vaccine carrying a hepatitis C virus truncated NS3 and core fusion protein].
    Guan J; Deng Y; Chen H; Yang Y; Wen B; Tan W
    Bing Du Xue Bao; 2015 Jan; 31(1):7-13. PubMed ID: 25997323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus: current concepts and future challenges.
    Klenerman P; Gupta PK
    QJM; 2012 Jan; 105(1):29-32. PubMed ID: 22123990
    [No Abstract]   [Full Text] [Related]  

  • 19. [Present status of developing hepatitis C vaccines].
    Arakawa Y; Moriyama M; Shikata T
    Nihon Naika Gakkai Zasshi; 1994 Feb; 83(2):245-51. PubMed ID: 7525800
    [No Abstract]   [Full Text] [Related]  

  • 20. Unscrambling hepatitis C virus-host interactions.
    Chisari FV
    Nature; 2005 Aug; 436(7053):930-2. PubMed ID: 16107831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.